Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

‘Hey, ChatGPT: Surgery or the Cath Lab?’ Study Shows AI Can Aid Decision-Making

Yael L. Maxwell

August 14, 2024

News Conference News TCT 2022

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

L.A. McKeown

September 18, 2022

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

News Conference News ACC 2021

Wide Variation in TAVI Readmission Rates Among US Hospitals

L.A. McKeown

May 07, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

Shelley Wood

April 02, 2021

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Daily News

Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación

Caitlin E. Cox

November 23, 2015

News Conference News TCT 2015

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

October 14, 2015

News Daily News

La FDA Aprueba 2 Nuevos Sistemas TAVR para Pacientes de Alto Riesgo e Inoperable

Yael L. Maxwell

June 24, 2015

News Daily News

Techniques to Lower Radiation Dose in TAVR Feasible

L.A. McKeown

May 13, 2015

News Daily News

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

October 03, 2014

Presentation TCT 2014

Bleeding Events (Early and Late) After TAVR: An Important and Often Misunderstood Complication

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Philippe Généreux

September 14, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

News Daily News

Los Resultados Iniciales TAVR son Equiparables a los Resultados PARTNER, aunque con Menos Complicaciones

Jason Kahn

January 01, 2014

News Daily News

La Rotura de la Raíz Aórtica secundaria a la TAVR es Peligrosa pero Predecible

Caitlin E. Cox

June 28, 2013

Advertisement

‘Hey, ChatGPT: Surgery or the Cath Lab?’ Study Shows AI Can Aid Decision-Making

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Wide Variation in TAVI Readmission Rates Among US Hospitals

TCTMD’s Top 10 Most Popular Stories for March 2021

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

La FDA Aprueba 2 Nuevos Sistemas TAVR para Pacientes de Alto Riesgo e Inoperable

Techniques to Lower Radiation Dose in TAVR Feasible

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

Bleeding Events (Early and Late) After TAVR: An Important and Often Misunderstood Complication

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Los Resultados Iniciales TAVR son Equiparables a los Resultados PARTNER, aunque con Menos Complicaciones

La Rotura de la Raíz Aórtica secundaria a la TAVR es Peligrosa pero Predecible

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content